The store will not work correctly when cookies are disabled.
6-(4-fluoro-3-methylphenyl)-1-(pyridin-2-ylmethyl)-1H-pyrrolo[3,2-b]pyridine
ID: ALA4539619
PubChem CID: 124176026
Max Phase: Preclinical
Molecular Formula: C20H16FN3
Molecular Weight: 317.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(-c2cnc3ccn(Cc4ccccn4)c3c2)ccc1F
Standard InChI: InChI=1S/C20H16FN3/c1-14-10-15(5-6-18(14)21)16-11-20-19(23-12-16)7-9-24(20)13-17-4-2-3-8-22-17/h2-12H,13H2,1H3
Standard InChI Key: QMNIVESMZXTVLD-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
15.1207 -9.2243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1196 -10.0439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8276 -10.4528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8259 -8.8155 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5345 -9.2207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5393 -10.0439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3237 -10.2937 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.8037 -9.6249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3159 -8.9618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4116 -10.4519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7058 -10.0413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9983 -10.4487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9972 -11.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7095 -11.6757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4142 -11.2660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7118 -12.4929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2897 -11.6757 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
17.5807 -11.0694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3810 -11.2347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6333 -12.0127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4328 -12.1781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9770 -11.5673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7161 -10.7884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9173 -10.6267 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
2 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
14 16 1 0
13 17 1 0
7 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 317.37 | Molecular Weight (Monoisotopic): 317.1328 | AlogP: 4.59 | #Rotatable Bonds: 3 |
Polar Surface Area: 30.71 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.03 | CX LogP: 4.36 | CX LogD: 4.35 |
Aromatic Rings: 4 | Heavy Atoms: 24 | QED Weighted: 0.55 | Np Likeness Score: -1.98 |
References
1. Chrovian CC, Soyode-Johnson A, Wall JL, Rech JC, Schoellerman J, Lord B, Coe KJ, Carruthers NI, Nguyen L, Jiang X, Koudriakova T, Balana B, Letavic MA.. (2019) 1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric Modulators., 10 (3): [PMID:30891123] [10.1021/acsmedchemlett.8b00542] |